[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @psil_ai Psychedelic News Alerts Psychedelic News Alerts posts on X about $rvvtf, $numif, $mnmd, $atai the most. They currently have XX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1687163039307481109/interactions)  - X Week XXXXX +49% - X Month XXXXX -XX% - X Months XXXXXX +1,777% - X Year XXXXXX +352% ### Mentions: XX [#](/creator/twitter::1687163039307481109/posts_active)  - X Months XX +100% - X Year XX +190% ### Followers: XX [#](/creator/twitter::1687163039307481109/followers)  - X Week XX +2.10% - X Month XX +8.90% - X Months XX +36% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1687163039307481109/influencer_rank)  ### Social Influence [#](/creator/twitter::1687163039307481109/influence) --- **Social category influence** [stocks](/list/stocks) [countries](/list/countries) **Social topic influence** [$rvvtf](/topic/$rvvtf) #1, [$numif](/topic/$numif) #1, [$mnmd](/topic/$mnmd) #4, [$atai](/topic/$atai) #17, [$cmps](/topic/$cmps) #5, [$cybn](/topic/$cybn) #3, [marks](/topic/marks), [australia](/topic/australia) **Top assets mentioned** [ATAI Life Sciences (ATAI)](/topic/$atai) ### Top Social Posts [#](/creator/twitter::1687163039307481109/posts) --- Top posts by engagements in the last XX hours "#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1945106405632905600) 2025-07-15 13:01:20 UTC XX followers, XXX engagements ""#Cybin's Phase X study EMBRACE to enroll XXX participants at XX sites in US Europe & Australia. Approval from UK MHRA marks progress in developing new treatments for MDD. #innovation" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1946238828685004993) 2025-07-18 16:01:10 UTC XX followers, XXX engagements "#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1943656854128582701) 2025-07-11 13:01:20 UTC XX followers, XXX engagements "#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1945151703105327326) 2025-07-15 16:01:19 UTC XX followers, XXX engagements "#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1944834575873556909) 2025-07-14 19:01:10 UTC XX followers, XXX engagements ""CYBN receives MHRA approval for Phase X EMBRACE study expected to enroll XXX participants at XX sites. Potential to transform MDD treatment." #innovation #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1946193556755861773) 2025-07-18 13:01:17 UTC XX followers, XXX engagements "#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1942569660978757805) 2025-07-08 13:01:13 UTC XX followers, XXX engagements ""Cybin's Phase X PARADIGM program progresses with MHRA approval for EMBRACE study aiming to enroll XXX participants and generate critical data for CYB003 in treating MDD. #pharmaceuticals" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1945876400340103583) 2025-07-17 16:01:01 UTC XX followers, XXX engagements "#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1945514068476903843) 2025-07-16 16:01:14 UTC XX followers, XXX engagements "#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1942932065084707094) 2025-07-09 13:01:16 UTC XX followers, XXX engagements "#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1943294422759731349) 2025-07-10 13:01:09 UTC XX followers, XXX engagements ""Phase X study EMBRACE part of PARADIGM program for CYB003 receives MHRA approval and aims to enroll XXX participants signaling potential for transforming depression treatment. #innovativetherapeutics" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1945831132840305107) 2025-07-17 13:01:08 UTC XX followers, XXX engagements "#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1942207275797537255) 2025-07-07 13:01:13 UTC XX followers, XXX engagements "#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1945468787316203991) 2025-07-16 13:01:18 UTC XX followers, XXX engagements "#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"  [@psil_ai](/creator/x/psil_ai) on [X](/post/tweet/1944744059404181981) 2025-07-14 13:01:30 UTC XX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@psil_ai Psychedelic News Alerts
Psychedelic News Alerts posts on X about $rvvtf, $numif, $mnmd, $atai the most. They currently have XX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +49%
- X Month XXXXX -XX%
- X Months XXXXXX +1,777%
- X Year XXXXXX +352%
Mentions: XX #
- X Months XX +100%
- X Year XX +190%
Followers: XX #
- X Week XX +2.10%
- X Month XX +8.90%
- X Months XX +36%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks countries
Social topic influence $rvvtf #1, $numif #1, $mnmd #4, $atai #17, $cmps #5, $cybn #3, marks, australia
Top assets mentioned ATAI Life Sciences (ATAI)
Top Social Posts #
Top posts by engagements in the last XX hours
"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-15 13:01:20 UTC XX followers, XXX engagements
""#Cybin's Phase X study EMBRACE to enroll XXX participants at XX sites in US Europe & Australia. Approval from UK MHRA marks progress in developing new treatments for MDD. #innovation" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF" @psil_ai on X 2025-07-18 16:01:10 UTC XX followers, XXX engagements
"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF" @psil_ai on X 2025-07-11 13:01:20 UTC XX followers, XXX engagements
"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF" @psil_ai on X 2025-07-15 16:01:19 UTC XX followers, XXX engagements
"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF" @psil_ai on X 2025-07-14 19:01:10 UTC XX followers, XXX engagements
""CYBN receives MHRA approval for Phase X EMBRACE study expected to enroll XXX participants at XX sites. Potential to transform MDD treatment." #innovation #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF" @psil_ai on X 2025-07-18 13:01:17 UTC XX followers, XXX engagements
"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF" @psil_ai on X 2025-07-08 13:01:13 UTC XX followers, XXX engagements
""Cybin's Phase X PARADIGM program progresses with MHRA approval for EMBRACE study aiming to enroll XXX participants and generate critical data for CYB003 in treating MDD. #pharmaceuticals" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF" @psil_ai on X 2025-07-17 16:01:01 UTC XX followers, XXX engagements
"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF" @psil_ai on X 2025-07-16 16:01:14 UTC XX followers, XXX engagements
"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF" @psil_ai on X 2025-07-09 13:01:16 UTC XX followers, XXX engagements
"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF" @psil_ai on X 2025-07-10 13:01:09 UTC XX followers, XXX engagements
""Phase X study EMBRACE part of PARADIGM program for CYB003 receives MHRA approval and aims to enroll XXX participants signaling potential for transforming depression treatment. #innovativetherapeutics" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF" @psil_ai on X 2025-07-17 13:01:08 UTC XX followers, XXX engagements
"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF" @psil_ai on X 2025-07-07 13:01:13 UTC XX followers, XXX engagements
"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF" @psil_ai on X 2025-07-16 13:01:18 UTC XX followers, XXX engagements
"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF" @psil_ai on X 2025-07-14 13:01:30 UTC XX followers, XXX engagements